The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 4, 2000, Pages 445-451

  Jung, Oliver ^a   Englert, Heinrich C ^a   Jung, Wolfgang ^a   Gögelein, Heinz ^a   Schölkens, Bernward A ^a   Busch, Andreas E ^a   Linz, Wolfgang ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Glibenclamide HMR 1883; Ischemic preconditioning; Mitochondrial K(ATP) channel blockade; Myocardial infarction; Rabbits; Sarcolemmal

Indexed keywords

1 [[5 [2 (5 CHLORO 2 ANISAMIDO)ETHYL] 2 METHOXYPHENYL]SULFONYL] 3 METHYLTHIOUREA; CLAMIKALANT; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; RABBIT; SARCOLEMMA;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; GLYBURIDE; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; POTASSIUM CHANNEL BLOCKERS; RABBITS; SULFONAMIDES; THIOUREA;

EID: 0034059080     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900212     Document Type: Article

References (34)

1. ATP channels. J Cardiovasc Electrophysiol 10:741-754
2. Belles B, Hescheler J, Trube G (1987) Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflugers Arch 409:582-588
3. Billman G, Englert HC, Schölkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286:1465-1473
4. Birnbaum Y, Hale SL, Kloner RA (1997) Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 29:657-666
5. ATP channel blocker HMR 1883 attenuates effects of ischemia on MAP duration and improves survival during LAD occlusion in the anesthetized pig. Br J Pharmacol 124:27P
6. + channels in cardiac ischemia: An endogenous mechanism for protection of the heart. Cardiovasc Drugs Ther 7:527-537
7. Daut J, Maier-Rudolph W, Beckrath N von, Mehrke G, Günther K, Goedel-Meinen L (1990) Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341-1344
8. Faivre JF, Findlay I (1989) Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochim Biophys Acta 984:1-5
9. + channels. J Biol Chem 263:7933-7936
10. Fralix TA, Steenbergen C, London RE, Murphy E (1993) Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 27:630-637
11. + channels. Circ Res 81:1072-1082
12. Gögelein H, Hartung H, Englert HC, Schölkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: Effects on cardiomyocytes, coronary flow and pancreatic β-cells. J Pharmacol Exp Ther 286:1453-1464
13. Gross GJ, Auchampach JA (1992) Blockade of ATP sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233
14. + channels and myocardial preconditioning. Circ Res 84:973-979
15. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB (1995) Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 30:731-738
16. Hartman JG, Kurc GM, Hullinger TG, Wall TM (1994) Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat. J Pharmacol Exp Ther 270:1071-1078
17. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 273:13578-13582
18. Janse MJ, Wit AL (1989) Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69:1049-1169
19. 1 adenosine receptors in rabbit heart. Circulation 84:350-356
20. Liu Y, Downey JM (1992) Ischemic preconditioning protects against infarction in rat hearts. Am J Physiol 263:H1107-H1112
21. Liu Y, Sato T, O'Rourke B, Marban E (1998) Mitochondrial ATP-dependent potassium channels. Novel effectors of cardioprotection? Circulation 97:2463-2469
22. McFalls EO, Pantley GA, Ophuis TO, Anselone CG, Bristow JD (1987) Relation of lactate production to postischemic reduction in function to post-myocardial oxygen consumption after partial coronary occlusion in swine. Cardiovasc Res 21:856-862
23. Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Imura O (1995) Glibenclamide, a blocker of ATP sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol 25:531-538
24. ATP channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Basic Res Cardiol 91: 382-388
25. Murry C, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
26. Reimer KA, Jennings RB (1996) Ischemic preconditioning: A brief review. Basic Res Cardiol 91:1-4
27. 2+ in anoxic rat ventricular myocytes. Effects of glibenclamide. Pflugers Arch 432:75-80
28. ATP channels in ischemic cardioprotection. Circulation (in press)
29. Steenbergen C, Fralix TA, Murphy E (1993) Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 88:456-470
30. + channel openers? Trends Pharmacol Sci 20:157-161
31. Toombs CT, Moore TL, Shebuski RJ (1993) Limitation of infarct size in the rabbit by ischemic preconditioning is reversible with glibenclamide. Cardiovasc Res 27:617-622
32. ATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 28:1337-1341
33. Wirth KJ, Rosenstein B, Uhde J, Englert HC, Busch AE, Schölkens BA (1999a) ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion. J Pharmacol Exp Ther 291:474-481
34. ATP channel blocker, inhibits ischaemia- And reperfusion-induced ventricular fibrillation in rats. Naunyn-Schmiedeberg's Arch Pharmacol 360:295-300